Literature DB >> 15689405

Genetic hypercalciuria.

Orson W Moe1, Olivier Bonny.   

Abstract

Hypercalciuria is an important, identifiable, and reversible risk factor in stone formation. The foremost and most fundamental step in dissecting the genetics of hypercalciuria is understanding its pathophysiology. Hypercalciuria is a complex trait. This article outlines the various factors that compromise the attempt to dissect the genetics of hypercalciuria, summarizes the clinical and experimental monogenic causes of hypercalciuria, and outlines the initial results from attempts in studying polygenic hypercalciuria. Finally, the problem is set in perspective of the current database, technologic advances and limitations are highlighted, and prospects of further advances in the field are speculated upon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689405     DOI: 10.1681/ASN.2004100888

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Authors:  Yun-Sok Ha; Dong-Un Tchey; Ho Won Kang; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  Korean J Urol       Date:  2010-01-21

2.  Probiotics for prevention of urinary stones.

Authors:  John C Lieske
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

5.  Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Authors:  Nancy S Krieger; John R Asplin; Kevin K Frick; Ignacio Granja; Christopher D Culbertson; Adeline Ng; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

6.  Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.

Authors:  Austin C Luskin; Jody P Lulich; Sarah C Gresch; Eva Furrow
Journal:  Res Vet Sci       Date:  2019-01-04       Impact factor: 2.534

Review 7.  Genetic causes of hypercalciuric nephrolithiasis.

Authors:  Michael J Stechman; Nellie Y Loh; Rajesh V Thakker
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

8.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

9.  Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.

Authors:  John H Wiessner; Michael R Garrett; Richard J Roman; Neil S Mandel
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03

10.  Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.

Authors:  Wisit Cheungpasitporn; Stephen B Erickson; Andrew D Rule; Felicity Enders; John C Lieske
Journal:  J Urol       Date:  2015-11-17       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.